InvestorsHub Logo
Followers 16
Posts 1898
Boards Moderated 0
Alias Born 05/12/2016

Re: Investfor5years post# 53968

Wednesday, 05/17/2017 7:18:41 PM

Wednesday, May 17, 2017 7:18:41 PM

Post# of 140474
About a year ago, an evaluation was published showing the patent portfolio alone was worth around $4 per share at that time. To be fair, it certainly must be disclosed that Titan paid for the evaluation to be done, so one could question the veracity of their conclusions. However, the logic seemed sound and their comparative basis also seemed reasonable and correct. The direction the company has gone since then appears to be putting them in a position of better strength than that of a year ago. With the recent completion of Human Factors Engineering evaluations (the very thing which got Transenetrix shot down by the FDA last spring) that position appears to be even stronger moving forward. We (or I, at least)presume their recent completion of an IP portfolio review should have identified any potential patent conflicts, and the report was all positive so they presumably will have a fairly clear pathway to FDA approval when they are ready.They have been working with the FDA for years to help ensure approval, and had previously indicated that their plan to file a 510K with a predicate device also had FDA buy-in in advance. And they have had a couple more patent approvals come through in the past year.

That all being said, it's a crazy world out there. Believers on this message board seem to fall anywhere from $10 to $30 per share in their states hopes for PPS. I think it is more a matter of how long one wants to wait. FDA approval has to spike this up substantially, and the pathway getting to that point should have us passing enough substantial milestones that PPS would escape the grasp of the market makers and force itself up to something more in line with actual value of the technology.

I'm thinking, in direct response to your question, and just my opinion, of course... the $3 minimum you seek should be a slam dunk by next summer or fall; the announcement of the FDA filing near the end of the year should easily clear your $5 benchmark; and a couple years beyond that should easily exceed your "amazing" level by a good margin. And $10 a share is about when I can no longer be convinced to work any more. I'm in this for a shortcut to retirement. And a big party in Vegas!

Good luck to all of us!